Overview: In Uganda alone, frequent FMD outbreaks have resulted in losses amounting to millions annually. Between 2015 and ...

With the introduction of Dihydroartemisinin-piperaquine (DHAP) and artesunate-pyronaridine (ASPY) on the list of anti-malarial drugs available in Rwanda, the number of treatments that can be ...

In contrast, sales revenues from Anti-malarial drugs are forecast to decline from Ush100.9 billion ($27 million) in 2024 to ...

Share…Milestone Aims to Improve Safe, Equitable Malaria Care Globally The World Health Organisation (WHO) has achieved a ...

WHO prequalifies SD Biosensor’s STANDARD G6PD System to support safer administration of P. vivax malaria treatments: Geneva Friday, January 10, 2025, 13:00 Hrs [IST] The World H ...

Caco-2 permeability is an important indicator of intestinal absorption and oral bioavailability, crucial for orally administered drugs. Higher permeability implies better absorption, enhancing ...

Dr Daniel Madandi, Director of WHO’s Global Malaria Programme, encouraged the submission of additional products to expand the range of diagnostic tools available to countries.

The discovery of the pGlu-CSP epitope opens up new avenues for developing next-generation malaria vaccines and treatments.

Augusta Cueva-Agila explains how the Cinchona officinalis, native to the Andean foothills, produced the world’s first anti-malarial drug ...

In the remote village of Panzi, nestled deep within Kwango province in the Democratic Republic of Congo (DRC), a deadly ...